Running Point Capital Advisors, LLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 95 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
Running Point Capital Advisors, LLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2022$14,000
-22.2%
15,0000.0%0.01%
-25.0%
Q2 2022$18,000
-10.0%
15,0000.0%0.01%0.0%
Q1 2022$20,00015,0000.01%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2022
NameSharesValueWeighting ↓
VHCP Management, LLC 1,102,735$3,485,0003.61%
VHCP Management II, LLC 280,000$885,0000.53%
GREAT POINT PARTNERS LLC 550,116$1,738,0000.50%
JW Asset Management, LLC 189,919$600,0000.48%
DAFNA Capital Management LLC 140,600$444,0000.35%
Granite Point Capital Management, L.P. 186,544$589,0000.25%
SABBY MANAGEMENT, LLC 779,926$2,465,0000.13%
TFS CAPITAL LLC 159,364$504,0000.09%
Rhenman & Partners Asset Management AB 154,006$487,0000.09%
Numeric Investors LLC 1,134,931$3,586,0000.03%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders